Graf Von Stosch patent opposition analysis

The comprehensive analysis of Graf Von Stosch opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Graf Von Stosch

Patent NumberTitleApplicantOpposition DateOpposition Company
Formulation For Anti-Alpha4Beta7 AntibodyMILLENNIUM PHARMACEUTICALS, INC.Sep 9, 2026LEPTHIEN
Chimeric Antigen Receptor (Car) With Antigen Binding Domains To The T Cell Receptor Beta Constant RegionAUTOLUS LIMITEDJan 30, 2026KIVIAL
Heart Valve Anchoring DeviceTRICARESSep 11, 2025T HEART
Improved Lipid Nanoparticles For Delivery Of Nucleic AcidsACUITAS THERAPEUTICS, INC.Apr 1, 2025GRAF VON STOSCH
Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses ThereofMODERNATX, INC.Feb 17, 2023WITHERS & ROGERS
Respiratory Virus VaccinesMODERNATX, INC.Jan 26, 2023WITHERS & ROGERS
Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA THERAPEUTICS, INC.Dec 2, 2022WITHERS & ROGERS
Terminally Modified RnaMODERNANov 23, 2022WITHERS & ROGERS
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNASep 1, 2022WITHERS & ROGERS
Heart Valve Anchoring DeviceTRICARESSep 15, 2021T HEART